drugset / Trial / NCT03002779
A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to determine the routes of excretion for JNJ-53718678 and its metabolites, to explore the metabolic pathways of JNJ-53718678, and to determine the chemical structure of predominant metabolites in healthy adult male participants after a single oral dose of 500 milligram (mg) 14C-JNJ-53718678.
Timeline
- Start
- 2017-01-26
- Primary completion
- 2017-03-10
- Completion
- 2017-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rilematovir | Other / unclassified | 500 mg | Oral |
Indications
No indication recorded.